Glenmark Pharmaceuticals
GLENMARK.NS
#2641
Rank
โ‚น435.03 B
Marketcap
โ‚น1,542
Share price
0.06%
Change (1 day)
87.51%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): โ‚น9.02

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น9.37. In 2022 the company made an earnings per share (EPS) of โ‚น33.18 a decrease over its 2021 EPS that were of โ‚น41.57.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น9.02-72.82%
2022โ‚น33.18-20.18%
2021โ‚น41.577.13%
2020โ‚น38.8125.72%
2019โ‚น30.87-22.01%
2018โ‚น39.5830.15%
2017โ‚น30.41-34.82%
2016โ‚น46.6663.09%
2015โ‚น28.619.68%
2014โ‚น26.08-26.58%
2013โ‚น35.530.51%
2012โ‚น35.35